139 related articles for article (PubMed ID: 38689257)
21. Oral artemisinin monotherapy removal from the private sector in Eastern Myanmar between 2012 and 2014.
Khin HS; Aung T; Thi A; White C;
Malar J; 2016 May; 15(1):286. PubMed ID: 27216408
[TBL] [Abstract][Full Text] [Related]
22. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.
Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM
Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179
[TBL] [Abstract][Full Text] [Related]
23. The malaria testing and treatment market in Kinshasa, Democratic Republic of the Congo, 2013.
; Mpanya G; Tshefu A; Likwela JL
Malar J; 2017 Feb; 16(1):94. PubMed ID: 28241832
[TBL] [Abstract][Full Text] [Related]
24. Trends in access to anti-malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first-line anti-malarials and diagnostics between 2007 and 2018.
Kibira D; Ssebagereka A; van den Ham HA; Opigo J; Katamba H; Seru M; Reed T; Leufkens HG; Mantel-Teeuwisse AK
Malar J; 2021 Mar; 20(1):142. PubMed ID: 33691704
[TBL] [Abstract][Full Text] [Related]
25. Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya.
Watsierah CA; Ouma C
Malar J; 2014 Jul; 13():290. PubMed ID: 25066600
[TBL] [Abstract][Full Text] [Related]
26. Drugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: implications for malaria treatment policy.
Ezenduka CC; Ogbonna BO; Ekwunife OI; Okonta MJ; Esimone CO
Malar J; 2014 Jun; 13():243. PubMed ID: 24961280
[TBL] [Abstract][Full Text] [Related]
27. Case management of malaria fever in Cambodia: results from national anti-malarial outlet and household surveys.
Littrell M; Gatakaa H; Phok S; Allen H; Yeung S; Chuor CM; Dysoley L; Socheat D; Spiers A; White C; Shewchuk T; Chavasse D; O'Connell KA
Malar J; 2011 Oct; 10():328. PubMed ID: 22039922
[TBL] [Abstract][Full Text] [Related]
28. Subsidising artemisinin-based combination therapy in the private retail sector.
Opiyo N; Yamey G; Garner P
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009926. PubMed ID: 26954551
[TBL] [Abstract][Full Text] [Related]
29. Assessing availability, prices, and market share of quality-assured malaria ACT and RDT in the private retail sector in Nigeria and Uganda.
Woldeghebriel M; Aso E; Berlin E; Fashanu C; Kirumira SN; Lam F; Mugerwa R; Nakiganda J; Olaleye T; Opigo J; Osinupebi F; Priestley N; Stringham R; Uhomoibhi P; Visser T; Ward A; Wiwa O; Woolsey A
Malar J; 2024 Feb; 23(1):41. PubMed ID: 38321459
[TBL] [Abstract][Full Text] [Related]
30. Availability and quality of anti-malarials among private sector outlets in Myanmar in 2012: results from a large, community-based, cross-sectional survey before a large-scale intervention.
Khin HS; Chen I; White C; Sudhinaraset M; McFarland W; Littrell M; Montagu D; Aung T
Malar J; 2015 Jul; 14():269. PubMed ID: 26169498
[TBL] [Abstract][Full Text] [Related]
31. The ACTwatch project: methods to describe anti-malarial markets in seven countries.
Shewchuk T; O'Connell KA; Goodman C; Hanson K; Chapman S; Chavasse D
Malar J; 2011 Oct; 10():325. PubMed ID: 22039780
[TBL] [Abstract][Full Text] [Related]
32. Healthcare professionals' perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda.
Ndagije HB; Kiguba R; Manirakiza L; Kirabira E; Sserwanga A; Nabirye L; Mukonzo J; Olsson S; Spinewine A; D'Hoore W; Speybroeck N
Malar J; 2020 Feb; 19(1):63. PubMed ID: 32041619
[TBL] [Abstract][Full Text] [Related]
33. Who continues to stock oral artemisinin monotherapy? Results of a provider survey in Myanmar.
Thein ST; Sudhinaraset M; Khin HS; McFarland W; Aung T
Malar J; 2016 Jun; 15():334. PubMed ID: 27333781
[TBL] [Abstract][Full Text] [Related]
34. Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment.
Maloney K; Ward A; Krenz B; Petty N; Bryson L; Dolkart C; Visser T; Le Menach A; Scott VK; Cohen JM; Mtumbuka E; Mkude S
Malar J; 2017 Jan; 16(1):6. PubMed ID: 28049481
[TBL] [Abstract][Full Text] [Related]
35. Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania.
Khatib RA; Selemani M; Mrisho GA; Masanja IM; Amuri M; Njozi MH; Kajungu D; Kuepfer I; Abdulla SM; de Savigny D
Malar J; 2013 May; 12():155. PubMed ID: 23651521
[TBL] [Abstract][Full Text] [Related]
36. Evidence of successful malaria case management policy implementation in Cambodia: results from national ACTwatch outlet surveys.
; Novotny J; Singh A; Dysoley L; Sovannaroth S; Rekol H
Malar J; 2016 Apr; 15():194. PubMed ID: 27059952
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies.
Briggs MA; Kalolella A; Bruxvoort K; Wiegand R; Lopez G; Festo C; Lyaruu P; Kenani M; Abdulla S; Goodman C; Kachur SP
PLoS One; 2014; 9(4):e94074. PubMed ID: 24732258
[TBL] [Abstract][Full Text] [Related]
38. Prescription practices and availability of artemisinin monotherapy in India: where do we stand?
Mishra N; Anvikar AR; Shah NK; Kamal VK; Sharma SK; Srivastava HC; Das MK; Pradhan K; Kumar H; Gupta YK; Gupta P; Dash AP; Valecha N
Malar J; 2011 Dec; 10():360. PubMed ID: 22166073
[TBL] [Abstract][Full Text] [Related]
39. Anti-malarial prescription practices among outpatients with laboratory-confirmed malaria in the setting of a health facility-based sentinel site surveillance system in Uganda.
Sears D; Kigozi R; Mpimbaza A; Kakeeto S; Sserwanga A; Staedke SG; Chang M; Kapella BK; Rubahika D; Kamya MR; Dorsey G
Malar J; 2013 Jul; 12():252. PubMed ID: 23870515
[TBL] [Abstract][Full Text] [Related]
40. Access to artemisinin-based combination therapies and other anti-malarial drugs in Kinshasa.
Nkoli Mandoko P; Sinou V; Moke Mbongi D; Ngoyi Mumba D; Kahunu Mesia G; Losimba Likwela J; Bi Shamamba Karhemere S; Muepu Tshilolo L; Tamfum Muyembe JJ; Parzy D
Med Mal Infect; 2018 Jun; 48(4):269-277. PubMed ID: 29530387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
